BCL2-Like 13 (Apoptosis Facilitator) (BCL2L13) (Internal Region) Peptide

Details for Product No. ABIN1382115, Supplier: Log in to see
Protein Name
  • si:ch211-238n5.7
  • Mil1
  • BCL-RAMBO
  • Bcl2-L-13
  • MIL1
  • E430016C20Rik
  • Mil-1
  • BCL2-like 13 (apoptosis facilitator)
  • BCL2L13
  • bcl2l13
  • Bcl2l13
Protein Region
Internal Region
Origin
Human
1
Application
Blocking Peptide (BP)
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Blocked Antibody anti-BCL2L13 antibody (BCL2-Like 13 (Apoptosis Facilitator)) (Middle Region) (ABIN1030885)
Characteristics 15 amino acids near the center of human Bcl-rambo
Human
Application Notes Bcl-rambo peptide is used for blocking the activity of the Bcl-rambo.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Kataoka, Holler, Micheau, Martinon, Tinel, Hofmann, Tschopp: "Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension." in: The Journal of biological chemistry, Vol. 276, Issue 22, pp. 19548-54, 2001 (PubMed).

Hugot, Chamaillard, Zouali, Lesage, Cézard, Belaiche, Almer, Tysk, OMorain, Gassull, Binder, Finkel, Cortot, Modigliani, Laurent-Puig, Gower-Rousseau, Macry, Colombel, Sahbatou, Thomas: "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 599-603, 2001 (PubMed).

Ogura, Bonen, Inohara, Nicolae, Chen, Ramos, Britton, Moran, Karaliuskas, Duerr, Achkar, Brant, Bayless, Kirschner, Hanauer, Nuñez, Cho: "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease." in: Nature, Vol. 411, Issue 6837, pp. 603-6, 2001 (PubMed).